Articles from American Gene Technologies

ROCKVILLE, MD / ACCESS Newswire / October 2, 2026 / American Gene Technologies ("AGT"), a clinical-stage biotech developing AGT103-T - the only program to demonstrate elimination of the HIV viral reservoir in humans - will present at the National Investment Banking Association (NIBA) 153rd Investment Conference on October 6-7, 2026.

All evaluable patients (n=5), demonstrated a significant reduction in Intact Proviral HIV DNA (IPDA) following treatment with AGT103-T